Efficacy and Tolerability of Topical LFX453 for External Genital Warts
NCT02482428
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
88
Enrollment
INDUSTRY
Sponsor class
Conditions
External Genital Warts
Interventions
DRUG:
Investigational Treatment
DRUG:
Aldara
Sponsor
Novartis Pharmaceuticals